68 results
Page 3 of 4
8-K
EX-99.1
owy7k63d2hkey29swf
8 Feb 22
MyMD Pharmaceuticals Announces Positive Clinical Data in Advance of Upcoming Phase 2 Trial of MYMD-1 for Extending Healthy Lifespan
9:20am
8-K
EX-99.1
vdsffdf85bnxga3b0
5 Jan 22
MyMD Pharmaceuticals Announces Issuance of New U.S. Patent Covering MYMD-1 in a Method of Treating Sarcopenia
9:28am
8-K
EX-99.1
bxou5o l4u0iynfg
16 Nov 21
MyMD Pharmaceuticals Receives FDA IND Clearance to Begin Phase 2 Trial of MYMD-1 for Extending Healthy Lifespan
9:25am
8-K
EX-99.1
2wyh ik2zqrsg
26 Oct 21
Regulation FD Disclosure
11:00am
8-K
EX-99.1
sgvquwyg7u0 ksmn
19 Oct 21
Regulation FD Disclosure
10:30am
8-K
EX-99.1
u3n1k16 tp0os8eqdys
5 Oct 21
MyMD Pharmaceuticals to Detail its Two Upcoming Phase 2 Trials
10:00am
8-K
EX-99.1
8xt9ou6hlx1ts7
22 Sep 21
MyMD Pharmaceuticals Announces New Data Demonstrating 8,000
12:52pm
8-K
EX-99.1
0w0lrlqw
13 Sep 21
MyMD Pharmaceuticals Announces Fourth Quarter 2021 Initiation of Phase 2 Clinical Trial of MYMD-1 for Extending Healthy Lifespan
5:30pm
425
rrauy7se
22 Mar 21
Business combination disclosure
5:21pm
S-4/A
3kh3lyhjgb3g1m
19 Mar 21
Registration of securities issued in business combination transactions (amended)
2:01pm
S-4
2odss7we9
15 Jan 21
Registration of securities issued in business combination transactions
5:24pm
425
molvl7p7z8p08kh9
2 Dec 20
Business combination disclosure
4:59pm
425
umxqcs
19 Nov 20
Business combination disclosure
8:48am
8-K
EX-99.1
3fahq823m5a61bphvnb
12 Nov 20
Akers Biosciences and MyMD Pharmaceuticals Sign Definitive Merger Agreement
5:26pm
424B5
hs80vs 6ri8s3cxnb
2 Nov 18
Prospectus supplement for primary offering
6:13am
424B4
oqbss
20 Dec 17
Prospectus supplement with pricing info
12:00am